All In Biotech

Free tool

FAERS Monitor: Infasurf Preservative Free

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming BLA 020521 or its brand name (Infasurf Preservative Free, Calfactant). Reports on generic versions are filed under their own applications.

Reports

63

Serious

60

95% of reports

Hospitalization

7

Death reported

11

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • endotracheal intubation complication25
  • oxygen saturation decreased13
  • bradycardia6
  • cardio-respiratory arrest5
  • pneumothorax4
  • death3
  • heart rate decreased3
  • neonatal hypoxia3
  • obstruction3
  • product quality issue3
  • pulmonary haemorrhage3
  • bradycardia neonatal2
  • breath sounds absent2
  • cardiac failure2
  • cardio-respiratory arrest neonatal2

Reports by year received

View as table
YearReports
20041
20071
20091
201316
20144
201510
201614
20174
20183
20193
20201
20211
20224

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,054,096 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
endotracheal intubation complicationSignal2514787.310787.1339,960
cardio-respiratory arrest neonatal28794.52207.79,637
breath sounds absent26188.71562.16,833
neonatal hypoxiaSignal31216.7402.42,521
bradycardia neonatal2532.2135.9595
obstructionSignal3250.983.1517
pulmonary haemorrhageSignal3128.142.4262
pneumothoraxSignal484.332.6251
oxygen saturation decreasedSignal1377.247.6906
cardio-respiratory arrestSignal539.917.2153
bradycardiaSignal637.817.7180
heart rate decreasedSignal328.59.555
cardiac failure28.32.17
product quality issueSignal37.42.411
death31.20.40

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.